Drug Profile
GEM 144
Latest Information Update: 20 Jan 2023
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Aceragen; Nonindustrial source
- Class Antisense oligonucleotides; Antivirals
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections